ArticlebioRxiv : the preprint server for biology2026
PUFA modulation of ASIC3 involves both specific and lipid solvent-like interactions.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Inflammatory mediators including polyunsaturated fatty acids (PUFAs) are known to potentiate ASIC3 by inducing changes in multiple gating features, yet the molecular basis for their interactions remains poorly defined. Using all-atom MD simulations and electrophysiology, we show that DHA accumulates around ASIC3 through loosely coordinated interactions with a membrane-facing electropositive region along the outer leaflet of TM1. In the open state, the carboxylate head group strongly binds to a critical arginine (R63) along with nearby polar residues that are necessary to slow the rate in channel desensitization rate but not to increase the pH sensitivity for channel activation. Moreover, mutating R63 disrupted effects on ASIC3 desensitization induced by PUFAs but not N-acyl amino acids (NAAAs) or lysophosphatidylcholines (LPCs). Our results provide the first detailed description of a functional PUFA binding site on ASICs, offering new insights into lipid modulation and potential strategies for developing novel therapeutics for pain and inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.